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Null mutations that cripple T cell receptor (TCR)
signaling explain rare primary immunodefi-
ciencies, but it is not understood why more
common polymorphisms that lead to subtle
TCR signaling defects are paradoxically associ-
ated with autoimmunity. Here we analyzed how
a series of Zap70 variants with step-wise
decreases in TCR signaling impacted upon
opposing TCR functions of immunity and toler-
ance. One Zap70 variant,murdock, moderately
decreased TCR signaling and thymic selection
without compromising immunological toler-
ance, whereas a more severe Zap70 defect,
mrtless, abolished thymic-positive selection
and led to immunodeficiency. Signaling capac-
ities between these two thresholds dispropor-
tionately compromised negative selection and
Foxp3+ regulatory T cell formation, creating a
cellular imbalance between immunogenic and
tolerogenic functions that resulted in the exces-
sive production of autoantibodies and immu-
noglobulin E (IgE). The pleiotropic functions
of ZAP-70 and their differential response to
graded variation provide a paradigm for under-
standing the complex outcomes of human
genetic variation.
INTRODUCTION
Precisely how genetic variation affects our susceptibility
to infection, autoimmunity, and allergy is only scarcely un-
derstood. The largest sources of human genetic variation912 Immunity 27, 912–926, December 2007 ª2007 Elsevier Incare single-nucleotide substitutions that occur approxi-
mately every 1000 nucleotides and affect all genes, and
copy number differences that affect 12% of genes (Re-
don et al., 2006). The chief effect of this variation is quan-
titative changes in the activity of specific gene products.
Although the capacity to produce knockout mice has
dramatically accelerated knowledge about the immuno-
logical consequences of complete loss of specific gene
products, we have remarkably little knowledge of the
immunological consequences of genetic variation at inter-
mediate states between ‘‘wild-type’’ and ‘‘null,’’ even for
pathways that are well defined.
Antigen recognition and T cell activation by the TCR is
one of the most well defined pathways of the immune sys-
tem, having been dissected inmice and humanswith loss-
of-function alleles in many of the critical components
(Kane et al., 2000). Loss of key enzymes in this pathway,
such as zeta-chain (TCR)-associated protein kinase
(ZAP-70), results in severe immunodeficiency in humans
and mice resulting from failure of the TCR to signal T cell
maturation in the thymus and T cell activation in the
periphery (Arpaia et al., 1994; Chan et al., 1994; Elder
et al., 1994; Negishi et al., 1995; Wiest et al., 1997). By
contrast, single-nucleotide substitutions affecting ZAP-
70 and other molecules in this pathway have recently
been identified that do not abolish T cell differentiation
or activation but are associated, paradoxically, with auto-
immunity and immunopathology. In mice, an amino acid
substitution in the C-terminal SH2 domain of ZAP-70
(W163C: Zap70skg) that decreases TCR signaling also
causes autoimmune arthritis when combined with sub-
clinical fungal infection and other genetic factors (Sakagu-
chi et al., 2003; Yoshitomi et al., 2005). Similarly, a single
amino acid substitution in the protein linker of activated
T cells (LAT), altering a tyrosine normally phosphorylated
by ZAP-70 (LATY136F), diminishes TCR signaling yet
causes a severe inflammatory and hyper-IgE syndrome.
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mans, a common nucleotide (PTPN221858T) and amino
acid (R620W) substitution in a protein tyrosine phospha-
tase, LYP, acts upon lymphocyte protein tyrosine kinase
(LCK) upstream of ZAP-70 to decrease TCR signaling
(Vang et al., 2005) and has been widely associated with
rheumatoid arthritis, Type 1 diabetes, systemic lupus er-
ythematosus, and autoimmune thyroid disease (Begovich
et al., 2004; Bottini et al., 2004; Criswell et al., 2005; Kyo-
goku et al., 2004; Velaga et al., 2004). Also upstream of
ZAP-70 is T cell-specific adaptor (TSAd), required for
optimal activation of ZAP-70 by LCK (Marti et al., 2006).
A promoter polymorphism in the gene encoding TSAd,
SH2D2A, is associated with multiple sclerosis and juvenile
rheumatoid arthritis (Dai et al., 2001; Smerdel et al., 2004).
Many more examples of partial defects in the TCR path-
way will no doubt emerge as new tools to resequence
genes or detect copy number variation are applied. Using
this genetic information will hinge upon understanding
howpartial defects in the efficiency of TCR signaling impact
upon regulation of autoimmunity and immunopathology.
It is not known how inherited defects in TCR signaling
translate into outcomes such as autoimmunity, hyper-
IgE, and immunopathology in some instances but not
others. One hypothesis is that the paradoxical variants
create a qualitative biochemical imbalance among parallel
signaling pathways within individual T cells. This could
cripple inhibitory feedback events to a greater extent
than activating events, such that T cell hyper-responsive-
ness or dysregulation occurs. For example, the LATY136F
point mutation selectively diminishes docking and activa-
tion of phospholipase C gamma while preserving docking
sites for many other signaling molecules in the LAT scaf-
fold, diminishing calcium flux but not activation of ERK
mitogen-activated protein kinase signaling. Similarly, the
amino acid substitution in the SH2 domain of ZAP-70skg
diminishes ZAP-70 binding to phosphorylated TCR zeta
chain immunoreceptor tyrosine-based activation motifs
(ITAMs), potentially increasing the recruitment and activa-
tion of parallel signaling molecules. An alternative hypoth-
esis is that simple quantitative differences in TCR signal-
ing in some cases create a qualitative cellular imbalance,
resulting from opposing actions of the TCR in different T
cells. In the thymus, TCR signaling triggers divergent func-
tions of positive and negative selection, depending upon
the strength of self peptide-MHC binding to unique
TCRs on each thymocyte (Daniels et al., 2006). Diminished
TCR signaling caused by ZAP-70skg or LATY136F enzymes
causes thymocytes with strongly self-reactive TCRs to
H-Y antigen to be positively selected instead of negatively
selected (Sakaguchi et al., 2003; Sommers et al., 2005).
This quantitative change in the positive versus negative
selection threshold might not be expected to result in
autoimmunity, however, because it also changes the acti-
vation threshold for peripheral T cells such that strongly
self-reactive T cells that are positively selected cannot
be activated by these antigens in the periphery (Sommers
et al., 2005). TCR signaling is also needed for the forma-
tion and activity of CD4+Foxp3+ regulatory T cells, andIa recent study suggests that deficiency of this inhibitory
subset accounts for the immunopathology and hyper-
IgE syndrome in LATY136F mice (Koonpaew et al., 2006).
TCR signaling is also needed to maintain peripheral naive
T cells, and when populations of these cells are reduced,
availability of IL-7 increases to facilitate activation of self-
reactive T cells (Baccala and Theofilopoulos, 2005).
Here we analyze how graded changes in TCR signaling
affect immune regulation by taking advantage of two
mutant mouse strains, each with partial defects in TCR
signaling because of amino acid substitutions within the
catalytic site of ZAP-70. One substitution had a modest
effect on TCR signaling and thymic development whereas
the other severely compromised both, with neither allele
resulting in autoimmunity or hyper-IgE in a homozygous
state. By contrast, autoimmunity and hyper-IgE arose
when these two Zap70 gene variants were intercrossed,
yielding animals with intermediate quantities of TCR sig-
naling that breached critical thresholds for thymic-nega-
tive selection and thymic-regulatory T cell formation. Our
analyses establish that inherited quantitative variation in
TCR signaling results in paradoxical autoimmune and im-
munocompromised states in some circumstances be-
cause of distinct cellular thresholds for opposing pleiotro-
pic actions of the TCR.
RESULTS
Identification of the Zap70 Variant Strainmurdock
The starting point for this study was a mouse genome-
wide screen for N-ethyl-N-nitrosourea (ENU)-induced sin-
gle-nucleotide substitutions affecting immune regulation
(Nelms and Goodnow, 2001). We identified one variant
C57BL/6 strain, murdock (mrd), with fewer peripheral T
cells of the naive CD44lo subset (Figure 1A). This T cell trait
was inherited in a recessive Mendelian fashion on the
C57BL/6 background and in an F2 intercross with the
NOD.H2k strain (Figure 1B) where 39 of 156 individuals
(25%) exhibited the murdock phenotype. A genome-
wide scan of pooled DNA from affected F2 mice linked
the trait toD1Mit212 on chromosome 1, with further typing
localizing the mutation to an 11 Mb interval between
D1Mit410 and D1Mit245 (Figure 1C). Within this interval,
the Zap70 gene (37.06 Mb) was a prime candidate, con-
sidering the arrest of ab T cell development in Zap70-
deficient mice (Negishi et al., 1995). Sequencing of
Zap70 cDNA from mrd homozygotes revealed a single A
to T transversion at base 1207 that was not present in
the parental C57BL/6 stock (see Figure S1A available on-
line). The mutation substituted an isoleucine codon for
phenylalanine (I367F) within the catalytic kinase domain
(Figure S1B) and was predicted to alter the dimensions
of the ATP-binding pocket within the catalytic cleft
(Figure S1C). For comparison, the W504R mrtless muta-
tion (described below) changes a conserved residue in
the activation loop within the catalytic site. The murdock
I367F mutation caused no measurable difference in
ZAP-70 protein expression between Zap70mrd/mrd and
wild-type C57BL/6 thymocytes (Figure 1D). In ammunity 27, 912–926, December 2007 ª2007 Elsevier Inc. 913
Immunity
ZAP-70 Variants in Immunity and ToleranceFigure 1. Fewer Naive T Cells in Mice with a ZAP-70I367F Catalytic Site Substitution, Zap70mrd/mrd
(A) Representative flow cytometry profiles of CD4 and CD8 expression upon peripheral blood lymphocytes, with representative histograms of CD44
expression on CD4+ and CD8+ T cells from unaffected and Zap70mrd/mrd mice.
(B) Initial generations of the Zap70mrd/mrd pedigree, including mapping intercross, showing affected (filled), unaffected (unfilled), and untyped
(crossed) mice.
(C) Meiotic mapping of the Zap70mrd/mrd mutation on chromosome 1. Haplotypes of affected Zap70mrd/mrd F2IC mice shown in columns: black
squares indicate C57BL/6 homozygosity, gray squares indicate C57BL/6-NOD.H2k heterozygosity. NM,markers not positioned on the current mouse
genome assembly.
(D) Anti-ZAP-70 immunoblot in C57BL/6 and Zap70mrd/mrd thymocytes.914 Immunity 27, 912–926, December 2007 ª2007 Elsevier Inc.
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I368F substitution in human ZAP-70 markedly decreased
total (aP-Tyr) and substrate-specific (aNTAL) phosphory-
lation (Figure 1E).
To confirm that the Zap70mrd I367F substitution was re-
sponsible for themurdock T cell phenotype, we performed
a genetic complementation cross with a second mouse
strain bearing a mutant copy of Zap70, mrtless (mrt),
discovered by the same screen in a parallel pedigree
(A.L.Y., O.M.S., S. Lesage, and C.C.G., unpublished
data). The Zap70mrt allele results from a W504R codon
change within the catalytic site, which in the homozygous
state reduces ZAP-70 protein expression to 25% of the
wild-type quantity and almost completely arrests T cell
development at the CD4+CD8+ thymocyte stage. From
a Zap70mrd/mrd by Zap70mrt/+ cross, approximately half
the offspring exhibited reduced percentages of CD4+
peripheral T cells (Figure 1F), confirming that themurdock
and mrtless T cell traits resulted from noncomplementary
alleles. This provided two ENU-induced Zap70 alleles,
with mild and severe losses of function in their respective
protein products.
Spontaneous Production of Autoantibodies
and Excessive Secretion of IgE and IgG1
in Zap70mrd/mrt Mice
Analysis of antibody production in the compound hetero-
zygousmurdock x mrtless (Zap70mrd/mrt) offspring yielded
the surprising result that, in contrast to wild-type Zap70+/+
control mice or the parental Zap70mrd/mrd or Zap70mrt/mrt
strains, 25 out of 27 murdock x mrtless mice had IgG
autoantibodies reactive to cytoplasmic or nuclear anti-
gens (Figure 2A). Furthermore, Zap70mrd/mrt mice sponta-
neously produced greatly increased amounts of IgE and
IgG1 antibodies (Figure 2B). Thus, the inheritance of two
different catalytically mutant forms of ZAP-70 triggered
dysregulated immune activity in a way that could not be
elicited by either mutant form in isolation.
This unique increase in spontaneous antibody secretion
in Zap70mrd/mrtmice contrasted with diminished acute IgG
antibody response to immunization (Figure 2C). Primary
Th1 responses to heat-killed Bordetella pertussis were
particularly sensitive to Zap70 defects, being equally
depressed to 2% of the wild-type response in each of
the three Zap70 mutant strains. Primary and secondary
responses to chicken gammaglobulin (CGG) and second-
ary responses to Arsonate hapten (ABA) conjugated to
CGG were absent in Zap70mrt/mrt mice (as might be ex-
pected given severe T cell deficiency in these animals)
and tended to be lower in Zap70mrd/mrt compound hetero-
zygotes than in Zap70mrd/mrd animals. Antibody responses
to the T-independent antigen NP-Ficoll were normal
across all Zap70 mutant strains. This indicated thatImZap70mrd/mrt mice had normal B cell activation thresholds
and impaired helper T cell function, in spite of enhanced
production of autoantibodies and IgE.
Graded and Threshold Decreases in Helper
T Cell Subsets
To understand why autoantibodies, hypergammaglobuli-
nemia, and hyper-IgE were selectively triggered in animals
coexpressing two different ZAP-70 catalytic site mutants,
we first compared the impact of different Zap70 genetic
states on the number of peripheral CD4+ T cells (Figure 3).
As expected, Zap70mrt/mrtmice had very few CD4+ T cells.
By contrast, Zap70mrd/mrd mice had half the number of
peripheral CD4+ T cells of wild-type controls (Figures 3A
and 3B)—this being due solely to a 70% decrease in naive
(CD44lo) CD4+ T cells while activated and memory
(CD44hi) CD4+ T cells remained in normal numbers (Fig-
ure 3D). The number of CD44lo CD4+ T cells was de-
creased by a further 60% in compound heterozygous
Zap70mrd/mrt animals, whereas there was still no impact
on the number of CD44hi cells. Thus, Zap70 genotype
had a graded impact on naive CD4+ T cells in the order
Zap70mrd/mrd > Zap70mrd/mrt > Zap70mrt/mrt,whereas a dis-
tinct threshold was required before thememory and effec-
tor compartmentwasnumerically affected.Graded effects
on naive CD4+ T cell number were mirrored in TCR-
induced calcium responses, which were subtly decreased
in T cells homozygous for Zap70mrd/mrd but dramatically
decreased in Zap70mrd/mrt T cells (Figure 3E). A distinct
threshold also applied to the CD8+ T cell subset, which
was not substantially reduced in Zap70mrd/mrd or
Zap70mrd/mrt individuals (because of a contraction in
CD44lo cells and expansion of the CD44hi subset) but
was greatly decreased in Zap70mrt/mrt animals. The prefer-
ential effect of the partial Zap70 defects on naive CD4+ T
cells caused a progressively skewed CD8+:CD4+ T ratio
that was most extreme in the Zap70mrd/mrt combination
(Figure 3C). These different thresholds for effects on
CD44lo and CD44hi subsets of CD4+ and CD8+ T cells
was consistent with the evidence that these subsets vary
in their relative dependence onTCRsignals for persistence
(Boyman et al., 2007; Caserta and Zamoyska, 2007).
To understand the origins of graded decreases in naive
CD4+ T cells, we examined the impact of the different
Zap70 states upon thymocyte differentiation (Figure 4).
Formation of CD4CD8+ thymocytes was not measurably
affected by the mild Zap70mrd allele, only slightly de-
creased by the Zap70mrd/mrt combination, but almost
completely abolished by homozygosity for Zap70mrt. By
contrast, five different manifestations of TCR signal
strength (Azzam et al., 1998; Naramura et al., 2002; Sosi-
nowski et al., 2001) showed step-wise decreases in the or-
derZap70+/+ >Zap70mrd/mrd > Zap70mrd/mrt > Zap70mrt/mrt;(E) ZAP-70 kinase assay in 293T cells cotransfected with NTAL, LCK, and wild-type (WT) or mutant human ZAP70 constructs (K369A, kinase-inactive;
I368F, Zap70mrd equivalent mutation; vector, no ZAP70 transfected). After 20 hr, cells were lysed and whole-cell lysates were immunoblotted with
antibodies indicated on right. Net intensity of P-Tyr (3100), as normalized to NTAL in the corresponding sample, is indicated below respective lanes.
(F) Pedigree schematic and low number of T cells in compound heterozygous offspring from parents bearing Zap70mrd and Zap70mrt missense
mutations. Filled symbols denote animals with low T cell numbers.munity 27, 912–926, December 2007 ª2007 Elsevier Inc. 915
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ZAP-70 Variants in Immunity and ToleranceFigure 2. Autoantibodies, Hypergammaglobulinemia, and Hyper-IgE in Zap70mrd/mrt, but Not Zap70mrd/mrd or Zap70mrt/mrt Mice
(A) Incidence and representative examples of IgG anti-nuclear or anti-cytoplasmic autoantibodies in 8- to 15-week-old mice of the indicated Zap70
genotypes.
(B) Concentration of serum IgE and IgG1 antibodies in unimmunized mice of the indicated genotypes as measured by ELISA.
(C) Relative ELISA titers of specific antibody to T-dependent (B. pertussis, CGG, ABA) and T-independent (NP2) immunogens 14 days and 6 days after
primary and secondary immunization, respectively. Asterisk indicates p < 0.05.CD4+CD8 T cell numbers (Figures 4A and 4B) and CD5,
CD69, TCRb, and CD33 expression upon CD4+CD8+ thy-
mocytes (Figure 4C; Figures S2B and S2C). Incidentally,
comparison of CD5 and CD69 expression in Zap70mrt/mrt
and homozygous null Zap70/ animals established that
Zap70mrt/mrt thymocytes have greater responsiveness to
TCR stimulation than thymocytes with no ZAP-70 (Fig-
ure S2B and A.L.Y., O.M.S., S. Lesage, and C.C.G.,
unpublished data). Decreased TCR and CD3 surface ex-
pression also occurred on single positive thymocytes
and peripheral T cells in a graded manner with expression
on Zap70mrd/mrt cells lower than Zap70mrd/mrd cells
(Figure S2C). Thus, inheritance of the mild Zap70mrd allele
together with the severe Zap70mrt allele diminished TCR
signaling to an intermediate point between the parental
homozygotes (and intermediate between wild-type and
null) with the resulting allelic series representing four
distinct efficiencies in TCR signaling.916 Immunity 27, 912–926, December 2007 ª2007 Elsevier IncGraded and Threshold Defects in Thymic
Tolerance in Zap70mrd/mrt Mice
To understand why step-wise decreases in TCR signaling
and CD4+ T cell formation selectively triggered autoanti-
bodies, hypergammaglobulinemia, and hyper-IgE at only
one point in our allelic series, we next asked whether there
was a threshold reduction in TCR signaling required to
disrupt self-tolerance by clonal deletion. TCR signaling
thresholds for negative selection are likely to differ for dif-
ferent TCRs, so we sought a consensus by analyzing poly-
clonal T cell populations expressing Vb5 or Vb11 TCRs
with a range of affinities for MMTV self-superantigen com-
plexed with I-E or I-A MHC molecules (Fink et al., 1994;
Kappler et al., 1987). Inmicewithwild-typeZap70, a prom-
inent subset of peripheral CD4+ and CD8+ T cells express
Vb5 or Vb11 in I-E-deficient H2b animals that express only
I-A, an MHC molecule that presents the self-superantigen
inefficiently (Figure 5A, open circles). These Vb5+ or Vb11+.
Immunity
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animals expressing I-E, which efficiently presents self-
superantigen to the T cells (Figure 5A, filled circles).
Homozygosity for the mild Zap70mrd defect interfered
with thymic-negative selection in I-E+ H2k animals, com-
pletely precluded negative selection of Vb11+ CD8+ T cells
(the least efficiently deleted subset in wild-type mice), and
allowed a substantial subset of Vb11+ CD4+ and Vb5+
CD8+ T cells to escape negative selection (Figure 5A).
These tolerance events exhibited a low threshold for dis-
ruption, as indicated by the fact that they were not further
exaggerated in Zap70mrd/mrt compound heterozygotes
with a more severe TCR signaling defect. By contrast,
clonal deletion of Vb5+ CD4+ T cells by I-E-MMTV ex-
hibited a higher threshold before disruption, because it
was mostly intact in Zap70mrd/mrd mice and became
defective only in Zap70mrd/mrt animals. Peripheral deletion
of Vb5+ CD4+ T cells by I-A-MMTV in H2b animals (Fink
et al., 1994) showed a graded deficit in response to differ-
ent TCR signaling lesions, with twice as many cells
remaining in Zap70mrd/mrd animals and three times as
many in Zap70mrd/mrt animals.
To analyze the impact on positive and negative selec-
tion of CD4+ T cells bearing a single TCR specificity,
Zap70mrd and Zap70mrt alleles were crossed with trans-
genic mice expressing a hen egg lysozyme (HEL)-I-Ak-
specific TCR (3A9) and insHEL expressed in pancreatic is-
let beta cells and thymic medullary epithelium (Akkaraju
et al., 1997; Liston et al., 2003). In mice lacking insHEL,
the number of CD4+ single-positive thymocytes express-
ing the 3A9 TCR was diminished to less than 2% of
Zap70+/+ numbers in the thymus (Figures 5B, 5D, and
5E) and 10% in the spleen (Figure 5C) of animals homozy-
gous for themild Zap70mrd allele. The small number of clo-
notype-positive CD4+ T cells that were positively selected
in spite of the Zap70mrd mutation may do so either based
on signals through the 3A9 receptor or through a coex-
pressed endogenous receptor. In either case, these data
demonstrated that positive selection of some TCRs was
acutely sensitive to modest changes in TCR signal
strength, thus extending the evidence in Figure 4A that
half as many CD4+CD8 thymocytes matured in
Zap70mrd/mrd thymi. Essentially no clonotype-positive
CD4+ T cells were present in TCR-transgenic Zap70mrd/mrt
compound heterozygotes (not depicted). In the thymus of
two sets of TCR insHEL double-transgenic mice analyzed,
there was little decrease in the number of clonotype-bear-
ing CD4+ T cells in Zap70mrd/mrd double transgenics com-
pared to Zap70mrd/mrd TCR animals, and their absolute
number was higher than the corresponding wild-type dou-
ble transgenic siblings analyzed at the same time (Figures
5D and 5E). The persistence of clonotype-bright CD4+ SP
thymocytes in Zap70mrd/mrd TCR insHEL animals could
have either been a direct effect of decreased TCR signal-
ing, an indirect effect of failure to exclude an endogenous
TCR-a chain, or a combination of the two. Regardless,
these data reinforced the previous evidence that negative
selection of some TCRs had a low threshold for disruption
by inherited changes in TCR signal strength.ImSelf-tolerance and suppression of IgG and IgE secretion
is also achieved through thymic selection and export of
self-reactive CD4+Foxp3+ regulatory T cells (Fontenot
and Rudensky, 2005). The absolute number of these cells
in the thymus was reduced 4-fold in Zap70mrd/mrd animals
(somewhat less than the overall reduction of CD4+ thymo-
cytes) such that they accounted for a slightly increased
proportion of CD4+ thymocytes (Figures 6A and 6B). The
number of CD4+Foxp3+ T cells was precipitously de-
creased to 10% of normal numbers in Zap70mrd/mrt
thymi—their numbers more severely decreased than
CD4+ thymocytes as a whole, such that they comprised
a smaller percentage of total CD4+ T cells. In the spleen,
however, CD4+Foxp3+ T cells were present in normal
numbers in both Zap70mrd/mrd and Zap70mrd/mrt animals,
indicating that peripheral homeostasis of this subset was
likely to be independent of TCR signaling. As a percentage
of splenic CD4+ T cells, Foxp3+ T cells were increased
2-fold because of the selective loss of naive CD4+ T cells
in Zap70mrd/mrd and Zap70mrd/mrt mutants. Although
a threshold effect upon thymic regulatory T cell formation
was masked in the peripheral CD4+Foxp3+ T cell pool, an
effect of the Zap70mrd/mrt TCR lesion was nevertheless
manifest in peripheral regulatory T cells, which expressed
much lower amounts of CD25 compared to those in
Zap70mrd/mrd or wild-type mice (Figure 6C). Together,
these results demonstrated that in addition to immuno-
genic mechanisms, tolerogenic mechanisms were also
altered by changes in the efficiency of TCR signaling.
Immune Dysregulation Caused by Zap70mrd/mrt
T Cells Is Not Suppressed by Wild-Type T Cells
The more severe defects in CD4+ T cell clonal deletion
and in CD4+Foxp3+ regulatory T cells in Zap70mrd/mrt
compound heterozygous mice provided two alternative,
although nonexclusive, explanations for the selective
occurrence of autoantibodies, hypergammaglobulinemia,
and hyper-IgE. To test these alternatives, we performed
in vivo cell mixing experiments to ask whether or not dys-
regulated help for antibody secretion was a cell-autono-
mous trait of Zap70mrd/mrt T cells or if it could be sup-
pressed in the presence of wild-type T cells. First, we
injected large numbers (33 107) of wild-type spleen cells
into young Zap70mrd/mrtmice. Although this did not correct
autoantibody or hyper-IgE secretion in Zap70mrd/mrt
animals (not depicted), the same procedure corrected
a similar antibody dysregulation in a SLP-76 hypomorphic
Lcp2 mutant mouse strain housed under identical condi-
tions (L.A.M., O.M.S., K. Asquith, P. Foster, A.L., and
C.C.G., unpublished data). Second, we reconstituted the
hematopoietic system of irradiated Rag1/ mice with
mixtures of fetal liver from CD45.1+ Zap70mrd/mrt and
wild-type or Foxp3/Y CD45.2+ donors. All recipients of
100% Foxp3/Y fetal liver, but not mixtures of Foxp3/Y
and Zap70mrd/mrt liver, became ill 6–7 weeks after recon-
stitution, indicating a functional competence of
Zap70mrd/mrt regulatory T cells sufficient to suppress
scurfy-like syndrome. In vivo Zap70mrd/mrt regulatory T cell
activity was also apparent when Foxp3/Y splenocytesmunity 27, 912–926, December 2007 ª2007 Elsevier Inc. 917
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ZAP-70 Variants in Immunity and ToleranceFigure 4. Four Allelic Graded States of TCR Signaling in Thymocytes
(A andB) Representative percentage of lymphocytes (A) and absolute number (B) of CD4CD8, CD4+CD8+, CD4+CD8, and CD4CD8+ thymocytes
in B10.Br mice of the indicated Zap70 genotypes. The lower number of CD4+CD8+ cells in Zap70mrt/mrt thymi is likely to reflect a difference in age,
because it was not significant in other experiments, nor was there any difference in CD4+CD8+ numbers when compared to Zap70/ mice
(A.L.Y., O.M.S., S. Lesage, and C.C.G., unpublished data).
(C) Normalized mean fluorescent intensities (MFI) of CD5, CD69, TCR-b, and CD33 expression upon CD4+CD8+ thymocytes, where the mean value in
wild-type cells represents 100 units. Asterisk indicates p < 0.05. Representative histograms are shown in Figure S1.were transferred into Rag1/ or Zap70mrd/mrt recipients,
because Rag1/ but not Zap70mrd/mrt recipients suc-
cumbed to a progressive loss of weight characteristic of
inflammatory bowel disease (Figure S2). With respect to
serology, a high background of serum autoantibodies in
all reconstituted Rag1/ recipients, regardless of donor
cell type, precluded any analysis of the Zap70mrd/mrt con-
tribution to this trait. By contrast, hyper-IgE occurred in all
Zap70mrd/mrt reconstituted animals and none of the controlImanimals reconstituted with wild-type fetal liver (Figure 7A).
In the mixed chimeras with wild-type or Foxp3/Y CD45.1
donors, there was no significant decrease in IgE com-
pared to the groups that received only Zap70mrd/mrt fetal
liver (Figure 7A). Flow cytometric analysis of the mixed
chimeras nevertheless demonstrated that between 10%
and 80% of the peripheral CD4+ T cells in these animals
were derived from the Zap70 wild-type CD45.1+ donor
(Figure 7B). Moreover, the mixed chimeras displayedFigure 3. Graded and Threshold Effects of Different Zap70 Alleles upon Peripheral T Cell Subsets
(A–C) Representative percentage of lymphocytes (A), absolute number (B), and ratio (C) of CD4+ and CD8+ T cells in spleens of mice with the indicated
Zap70 genotypes.
(D) Absolute numbers of CD4+ and CD8+ T cells within naive (CD44lo) or activated/memory (CD44hi) compartments. Asterisk indicates p < 0.05.
(E) Anti-CD3-induced calcium flux in CD4+ T cells from wild-type and Zap70mrd/mrd (top) or Zap70mrd/mrt mice (bottom).munity 27, 912–926, December 2007 ª2007 Elsevier Inc. 919
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ZAP-70 Variants in Immunity and ToleranceFigure 5. Threshold Effects of Decreased ZAP-70 Activity on CD4+ T Cell-Negative Selection
(A) Percentage of CD8+ or CD4+ T cells expressing Vb11 or Vb5 in peripheral blood lymphocytes of nontransgenic mice with the indicated Zap70
genotypes, and either H2b (open symbols) or H2k (filled) haplotypes. Asterisk indicates p < 0.05.
(B–D) Representative flow cytometry profiles and (B) percentages of thymocyte CD4+ and CD8+ subsets in TCR transgenic or TCR insHEL double-
transgenic mice with wild-type Zap70 or homozygous Zap70mrd/mrd.
(C) Spleen cells from the same mice as (B), stained for CD4 and the 3A9 TCR clonotype, 1G12.
(D) 1G12 clonotype staining on gated CD4+CD8 thymocytes from (B) and from a nontransgenic control. Numbers show percentage of CD4+CD8 T
cells, with bracketed numbers indicating percentage of all thymocytes, that are 1G12+ or 1G12hi.
(E) Absolute number of CD4+CD8 1G12hi T cells in the thymus of two animals of each genotype.920 Immunity 27, 912–926, December 2007 ª2007 Elsevier Inc.
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ZAP-70 Variants in Immunity and ToleranceFigure 6. Threshold Effects of Decreased ZAP-70 Activity on Foxp3+ Regulatory T Cells
(A) Representative flow cytometry profiles of CD4 and Foxp3 expression and percentage of CD4+Foxp3+ T cells in thymocytes or splenocytes from
mice of the indicated Zap70 genotypes.
(B) Absolute numbers and percentages of CD4+CD8 thymocytes or splenocytes expressing Foxp3. Asterisk indicates p < 0.05.
(C) Representative histogram overlay of CD25 expression upon CD4+Foxp3+ T cells from B10.Br (shaded), Zap70mrd/mrd (dotted), or Zap70mrd/mrt
(solid) mice.high IgE in spite of the presence of a high proportion of
wild-type CD4+Foxp3+ T cells (Figure 7C). Induction of
IgE secretion was therefore a cell-autonomous trait of
Zap70mrd/mrt T cells that was most likely due to the in-
creased frequency of self-reactive CD4+ T cells and could
not be complemented by wild-type CD4+Foxp3+ T cells.
DISCUSSION
Understanding the relationship between common and
rare inherited gene variants and immunological disease
is a major challenge. Our analysis provides a paradigm
for understanding this relationship, by demonstrating
how genetic variation resulting in quantitative changes in
the activity of a single well-characterized gene and bio-
chemical pathway (Zap70 and TCR signaling) has pleiotro-
pic threshold effects on the cellular components and over-
all function of the immune system. By comparing mice
inheriting four different allelic states of Zap70, we show
that system-wide immunological functions and the T cell
processes underpinning them have different thresholds
of robustness against genetic variation. Least robust
were Th1 responses to Bordetella pertussis vaccine, thy-Immic CD4+ T cell-positive selection, peripheral naive
CD4+ T cell numbers, and thymic-negative selection to
trace antigens under Aire control. These failed to varying
degrees, even with a subtle Zap70mrd/mrd allele. More
robust were germinal center memory antibody responses
(to ABA hapten), thymic-negative selection of many
clones, thymic Foxp3+ regulatory T cell formation, CD25
expression on peripheral Foxp3+ cells, and TCR-induced
calcium responses. These nevertheless failed dramati-
cally when a greater genetic perturbation, Zap70mrd/mrt,
was inherited. By contrast, help for secretion of IgE, IgG
autoantibodies, and IgG1 antibodies to protein antigens,
maintenance of CD44hi memory CD4+ and CD8+ T cells,
and thymic-positive selection of CD8+ T cells remained
intact in the face of the Zap70mrd/mrt combination. This dif-
ferential sensitivity of help versus tolerance resulted in
dysregulated overproduction of IgG and IgE antibodies
at intermediate genetic states between wild-type and
null. A recognizable primary immunodeficiency syndrome
with clear-cut deficiency of naive and memory CD4+ and
CD8+ T subsets and antibody response only arises when
ZAP-70 is severely compromised in Zap70mrt/mrt animals,
or when its function is abolished altogether in Zap70/munity 27, 912–926, December 2007 ª2007 Elsevier Inc. 921
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ZAP-70 Variants in Immunity and ToleranceFigure 7. Failure to Suppress IgE Secretion in Zap70mrd/mrt Chimeric Mice with Wild-Type CD4+Foxp3+ T Cells
(A) Irradiated Rag1/mice were reconstituted with mixtures of fetal liver cells fromCD45.2+ Zap70mrd/mrt and CD45.1+ wild-type or Foxp3/Y donors,
and serum IgEwasmeasured 6–7weeks after reconstitution. Columns showmedian values; ns, no significant difference; asterisk, significant p < 0.05,
between indicated experimental group and 100% Zap70mrd/mrt chimeras by Kruskal-Wallis test with Dunn’s post-test.
(B) Chimeric mice were analyzed at the same time for the percentage of CD4+ T cells derived from wild-type CD45.1+ donor stem cells.
(C) Flow cytometry profiles of CD45.1 and Foxp3 expression in CD4+ T cells from representative chimeric recipients. Serum IgE concentrations for
each mouse are given alongside.mice. As discussed below, these findings raise issues
about the relative contribution of different genetic and
cellular defects to common human immune diseases
and their mouse models, and the extent to which genetic
and cellular biomarkers may help to stratify common
human immune disease.
Autoantibodies, hypergammaglobulinemia, and ele-
vated IgE occur in a number of mousemodels where point
mutations partially compromise components of the TCR
signaling pathway, yet are absent in others. In simplest
terms, our analysis of graded defects in ZAP-70 explain
these paradoxical outcomes as resulting from lower
robustness of regulatory mechanisms compared to helper
mechanisms in CD4+ T cells, such that dysregulated help922 Immunity 27, 912–926, December 2007 ª2007 Elsevier Inmanifests when inherited defects reduce TCR signaling
to a critical intermediate point. Considering our Zap70
series together with other models, the pathogenesis of im-
mune dysregulation in individuals with diminished TCR
signaling appears multifactorial and pleiotropic, with vari-
able contributions from defects in thymic deletion, regula-
tory T cell formation and function, lymphopenia, and
immune deficiency and opportunistic infection.
Failure of thymic deletion and autologous responses of
CD4+ Th2 or Th17 cells has been suggested to cause
antibody dysregulation in LATY136F mice (Aguado et al.,
2002; Sommers et al., 2005) and arthritis and hypergam-
maglobulinemia in Zap70skg mice (Hirota et al., 2007;
Sakaguchi and Sakaguchi, 2005). Nevertheless, thisc.
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ZAP-70 Variants in Immunity and Tolerancetolerance defect is insufficient to cause dysregulation in
Zap70skg mice maintained in a specific pathogen-free
(SPF) facility or on a different inbred background (Jiang
et al., 2005). Similarly, there was already a marked failure
of thymic deletion in Zap70mrd/mrd mice that did not trans-
late into autoantibodies or hypergammaglobulinemia,
whereas a more severe failure of thymic deletion in
Zap70mrd/mrt individuals was accompanied by antibody
dysregulation. Intuitively, one might expect that a de-
crease in TCR signaling for thymic deletion would be
cancelled out by an equal decrease in TCR signaling for
activation in the periphery, such that the system tolerates
varying efficiencies of thymic deletion. The fact that hyper-
IgE in Zap70mrd/mrt mice was dominant in mixed chimeras
and was not suppressed by equal numbers of normal T
cells or regulatory T cells indicates a T cell-autonomous
defect such as escape from thymic deletion. Revealing
the signaling pathways and effector mechanisms required
for aberrant antibody production, through the introduction
of additional mutations, will be a point of future interest.
The role of lymphopenia and regulatory T cell deficiency
in immune dysregulation from partial TCR signaling
defects also appears to contribute to varying degrees.
Elevated IgE is characteristic of regulatory T cell defi-
ciency caused by mouse and human FOXP3 mutations
and of hypomorphic mouse and human RAG mutations
where there is a limited repertoire of competing T cells
(Khiong et al., 2007; Marrella et al., 2007; Villa et al.,
1998). Although antibody dysregulation in our Zap70 alle-
lic series correlated with a marked drop in thymic Foxp3+
CD4+ T cells and decreased CD25 expression on the
remaining cells, hyper-IgE in Zap70mrd/mrt mice was nev-
ertheless not suppressed by normal T cells or regulatory
T cells. This is a point of contrast with LATY136F mice,
in which pathology can be prevented by the transfer of
2–3 3 105 CD4+CD25+ T cells (Koonpaew et al., 2006).
CD4+CD25+adoptiveTcell transfer hasalsobeen reported
to prevent arthritis inZap70skgmice (Hirota et al., 2007; Sa-
kaguchi and Sakaguchi, 2005). These differing outcomes
may be explained by the robustness of different T cell
mechanisms: autoreactive helper cells in Zap70mrd/mrt
mice may retain sufficient TCR signaling for dysregu-
lated helper function in the face of normal regulatory
T cells. Alleles that produce enzymes with further re-
duced TCR signaling, such as ZAP-70skg or LATY136F,
may weaken autoreactive T helper function to an ex-
tent that dysregulated help only occurs when regula-
tory T cells are also crippled.
In addition to intrinsic T cell dysregulation, it has to be
considered that defective effector T cell functions that
allow opportunistic infection may play a contributory
role. Primary immunodeficiency disorders inman are often
associated with apparent autoimmune phenomena that
stem from a failure to control viral, bacterial, and fungal
infections (Arkwright et al., 2002). Opportunistic, subclini-
cal fungal infection with Pneumocystis or Aspergillus has
been shown to be an essential cofactor in arthritis devel-
opment in Zap70skgmice and appears to act by activating
dendritic cells, decreasing T cell IL-4 production, andImincreasing T cell interferon gamma production and IgG
secretion (Kobayashi et al., 2006; Yoshitomi et al., 2005).
These events transpire only in Zap70skgmice on a suscep-
tible BALB/c background (Jiang et al., 2005). The finding
that dysregulated IgE production in Zap70mrd/mrt mice
was not suppressed by large numbers of normal T cells
in adoptive transfer or mixed chimeras would argue
against opportunistic infection, because wild-type T cells
should restore immune competence. Moreover, Th1 re-
sponses to Bordetella immunization were equally crippled
by the Zap70mrd/mrd and Zap70mrd/mrt alleles, yet only the
latter was associated with dysregulated IgG and IgE se-
cretion. Like the role for regulatory T cell deficiency, there
may be variable interplay between primary T cell dysregu-
lation and opportunistic infection in mice with partial TCR
signaling lesions, depending upon the extent to which the
signaling pathway is compromised and upon other back-
ground genes.
A key issue highlighted by our Zap70 allelic series is the
extent to which genetic variation resulting in quantitative
changes in components of the TCR signaling pathway
blur the lines between immune dysregulation and primary
immunodeficiency. Given the number of genes encoding
components required for TCR signaling, the substantial
germline mutation rate, and large size of the human
population, comparable partial defects to Zap70mrd/mrt
may arise with substantial frequency in our population
through additive effects of inheriting heterozygous sin-
gle-nucleotide or copy-number variant alleles affecting
two or more elements of the TCR signaling pathway. The
recent discovery of a common functional polymorphism
in PTPN22 associated with various autoimmune diseases
is likely to be the tip of the iceberg of sporadic autoimmune
or allergic conditions where there is an underlying quanti-
tative defect in TCR signaling that does not meet the
extreme criteria for primary immunodeficiency. In the
future, biomarker assays based on the least robust T cell
mechanisms defined here, combined with resequencing
of genes in the TCR pathway, may provide a more sensi-
tive and specificway to stratify common immune dysregu-
lation disorders with this root cause.
EXPERIMENTAL PROCEDURES
Mice
Zap70mrd/mrd (MGI:3614796) was derived from a C57BL/6 G0 male
treated intraperitoneally with 100 mg/kg N-ethyl-N-nitrosourea
(Sigma) at three weekly intervals. Mutation mapping and DNA
sequencing were performed as previously described (Miosge et al.,
2002). Zap70mrd/mrd and Zap70mrt/mrt (MGI:3614790) strains were cre-
ated on a C57BL/6 background and analyzed on a mixed background
with B10.Br (B10.BR-H2k/SgSnJ). 3A9 TCR transgenic (Ho et al., 1994)
and ILK-3 insHEL transgenic (Akkaraju et al., 1997) mice were
produced on the C57BL/6J background, backcrossed more than
seven generations to B10.Br, backcrossed to Zap70mrd/mrd and
Zap70mrt/mrt strains, and finally intercrossed. Rag1/, Foxp3/Y,
NOD.H2k, and C57BL/6.Ly5a congenic mice have all been described
previously (Fontenot et al., 2003; Lesage et al., 2002; Miosge et al.,
2002; Mombaerts et al., 1992). Mice were fixed for H2k and used at
6–18 weeks of age unless otherwise specified. All mice were housed
in specific pathogen-free conditions at the Australian Phenomicsmunity 27, 912–926, December 2007 ª2007 Elsevier Inc. 923
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imal procedures approved by the Australian National University Animal
Ethics and Experimentation Committee.
Flow Cytometry
Lymphoid organ suspensions were labeled with FITC-conjugated
anti-CD4, anti-CD44, anti-CD45.2 (Ly5b), anti-CD69, anti-TCRb, anti-
CD33; PerCP-conjugated anti-CD8a; biotinylated anti-Vb5 and anti-
Vb11; APC-conjugated streptavidin (BD PharMingen); PE-conjugated
anti-CD25 and anti-CD5 (Caltag); and APC-conjugated anti-CD45.1
(Ly5a) (eBioscience). Intracellular calcium after stimulation with anti-
CD33 (500A2) was measured with a mixture of Ly5-marked spleno-
cytes labeled with Indo-1 (Molecular Probes). anti-Foxp3-FITC intra-
cellular staining was performed according to the manufacturer’s
recommended protocol (eBioscience).
293T Kinase Assay
The Zap70mrd mutation (ZAP-70I368F) was introduced into a human
ZAP-70-pcDNA3 construct with the QuikChange site-directed muta-
genesis kit (Stratagene, La Jolla, CA) according to the manufacturer’s
instructions. All other ZAP-70 constructs as well as cDNAs coding for
Lck and NTAL have been described previously (Brdicka et al., 2005).
NTAL and the endogenous ZAP-70 substrate LAT have subsequently
been found to be fully interchangeable in this assay. 293T cells were
transfected with Lipofectamine and PLUS Reagent (Invitrogen, Carls-
bad, CA) according to manufacturer’s instructions. After 20 hr, cells
were harvested, washed in PBS, and lysed in 60 ml 23 concentrated
SDS-PAGE sample buffer. Lysates were ultracentrifuged for 30 min
at 300,000 3 g at 20C and supernatants subjected to SDS-PAGE
and immunoblot with antibodies against phosphotyrosine (4G10, Up-
state Biotechnology, Charlottesville, VA), NTAL (NAP-4), ZAP-70
(2F3.2), or Lck (1F6, from J. Bolen, Millennium Pharmaceuticals,
Cambridge, MA).
Immunizations and ELISA
9- to 12-week-old mice were immunized by intraperitoneal injection
with alum-precipitated ABA-CGG (Biosearch Technology) and 5 3
108 whole killed Bordetella pertussis (Lee Labs, Becton Dickinson).
Five and a half weeks later, the samemicewere immunizedwith a com-
bination of ABA-CGG and NP2-Ficoll (Biosearch Technology). Mice
were bled 14 days after primary and 6 days after secondary immuniza-
tion. For antigen-specific ELISA, serially diluted sera were adsorbed to
plate-coated NP2-BSA, ABA-BSA, CGG, or sonicated B. pertussis
(Southern Biotechnology). For total antibody ELISA, dilute serum
was adsorbed to plate-bound anti-IgE (BD PharMingen) or goat anti-
mouse k light chain (Southern Biotechnology). Bound immunoglobu-
lins were detected by alkaline phosphatase-conjugated antibodies
specific to individual mouse isotypes (BD PharMingen) and quanti-
tated by phosphatase substrate (Kirkegaard and Perry Laboratories).
Sample concentrations were extrapolated from positive control
standard curves.
Autoantibodies
Serum-diluted 1/100 was applied to 12-well slides bearing permeabi-
lized human epithelial cell HEp-2 cells (INOVA Diagnostics), washed,
and then incubated with FITC-conjugated goat anti-mouse IgG
(Caltag). Mounted slides were scored in blinded fashion on a Zeiss Ax-
iophot microscope (Carl Zeiss) at 403 objective under ultraviolet light.
Fetal Liver Chimeras
E16 embryonic liver suspensions were prepared in RPMI supple-
mented with 10% fetal calf serum and mixed in the appropriate ratios.
23 105 viable cells were injected intravenously into irradiated Rag1/
recipients, which were sacrificed for analysis 6–7 weeks later.
Statistical Analysis
Where appropriate, one-way analysis of variance tests were per-
formed across all groups, with Bonferroni’s post-test used to deter-924 Immunity 27, 912–926, December 2007 ª2007 Elsevier Inmine significance as compared to the wild-type group. When data
were not in an approximately normal distribution, the nonparametric
Kruskal-Wallis test was used in combination with Dunn’s post-test.
Where p values were less than 0.05, an asterisk (*) was used to denote
statistical significance. Data from two or more independent experi-
ments were pooled in all figures. Unless otherwise indicated, bars
represent the mean value of each experimental group, with circles
representing individual mice.
Supplemental Data
Three figures are available at http://www.immunity.com/cgi/content/
full/27/6/912/DC1/.
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